WHO WE ARE

We are an Asian Population Health Company.

We are a bunch of highly experienced doctors, technologists, insurance experts and managed care practitioners who believe that we can use technology to improve the quality of Asian healthcare while lowering costs.

We also know what works in Asia, and we brought best-in-class technologies from around the world on to one platform to make that belief a reality.

We get paid on outcomes, plain and simple.

Board of Directors

Dr Ramesh Rajentheran – Executive Chairman

Dr Ramesh is the former CFO & COO of Fullerton Health, Asia’s largest Managed Care business. He was also the Managing Director and Head of Asian Healthcare Investment Banking at Barclays, Executive Director at Morgan Stanley & UBS and a Physician for the NHS.

Dr Jeremy Lim – Independent  Director

Partner in the Asian healthcare practice (which he founded in 2013) of a US-listed global consultancy. He is CEO of AMILI, the region’s first dedicated gut microbiome company. He chairs the steering committee of NIHA (NUS Initiative to Improve Health in Asia), and sits on the Advisory Council for Behavioural Sciences Institute (SMU), and Centre for Health Informatics (NUS). He consults regularly for international organisations such as the WHO and World Bank and also advises a number of health tech and digital health companies globally

Geoffrey Ng – Independent  Director

Two decades of investment management and leadership experience. Currently a Director with Fortress Capital Asset Management, a Pan-Asian investment management company, previously held the positions of Chief Executive Office/Executive Director with Hong Leong Asset Management and Chief Investment Officer with Pacific Mutual Fund. Geoffrey is a member of CFA Institutes Board of Governors, where he is Vice Chair of the Audit and Risk Committee. He is also an Independent, Non-Executive Chairman of Bursa Malaysia-listed Kronologi Asia Berhad.